COMMUNIQUÉS West-GlobeNewswire

Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration
18/08/2026
Peer-reviewed research points to the extracellular matrix, the framework that holds tissue together, as central to that work. More than a decade of research has gone into Conexeu’s CXU™ Platform Highlights Regenerative [...]
Polomar Health Services Reports Second-Quarter Revenue of $1.53 Million and Positive Net Income
18/08/2026
Commercial prescription fulfillment drives significant revenue growth, a 61.2% gross margin and improved operating cash flow PALM HARBOR, Fla., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Polomar Health Services, Inc. (OTCQB: [...]
ENvue Medical Announces Exclusive UroShield® Distribution Agreement with Minimum Purchase Commitments of Approximately $2.6 Million
18/08/2026
Multi-year agreement with Peak Medical expands UroShield commercialization across the United Kingdom and Republic of Ireland TYLER, Texas, Aug. 18, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) (“ENvue” or the “ [...]
Propanc Biopharma Clears Path for World-First Phase 1b Clinical Study of Breakthrough Cancer Therapy PRP
18/08/2026
Avance Clinical to Lead Preparatory Activities for Multi-Center Investigation Across Australia MELBOURNE, Australia, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company [...]
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufacturing Center
18/08/2026
Kennewick, WA, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), a medical device company pioneering Precision Radionuclide Therapy ™ (PRnT) for the treatment of cancerous tumors, today announced two [...]
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
18/08/2026
SOUTH SAN FRANCISCO, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced the receipt of Fast Track designation from the U.S. Food and Drug Administration (FDA) for PLN- [...]
Transactions in connection with share buy-back program
18/08/2026
Company announcement no. 31 - 26 18 August 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as described in company [...]
Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
18/08/2026
Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical [...]
Cloud 9 Vets calls on the CMA to add at-home pet euthanasia to the new mandatory vet price list
18/08/2026
Research by the UK in-home veterinary provider found 67% of pet owners had no idea a vet could come to the house to put pets to sleep. Chichester, West Sussex, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Cloud 9 Vets, a national [...]
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
18/08/2026
Dr. Charuworn’s extensive immunology drug development experience will help accelerate the clinical development of Coultreon’s first-in-class SIK3 inhibitor COL-5671 Leuven, Belgium. August 18, 2026 . Coultreon Biopharma [...]
Coloplast A/S - Interim Financial Report, 9M 2025/26
18/08/2026
Interim financial results, 9M 2025/26 1 October 2025 - 30 June 2026 Coloplast delivered Q3 organic growth of 6% and 5% EBIT growth 1 in constant currencies. Strong quarter in both Chronic Care ex. China and [...]
Basilea reports strong 2026 half-year results and raises full-year guidance; fosmanogepix phase 3 program on track
18/08/2026
Total revenue increases by 14% to CHF 119 million Operating profit increases by 32% to CHF 32 million and net profit by 77% to CHF 28 million Fosmanogepix phase 3 program on track for data readout and regulatory [...]
InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China
18/08/2026
BEIJING, Aug. 18, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the Center for [...]
MemoHoney Details Supplement Facts Panel, Serving Directions and Label Information
18/08/2026
Niacin, Calcium, L-Arginine, L-Arginine AKG, L-Citrulline HCl, L-Citrulline Malate and Beta Alanine Combine in a 30-Capsule Memory, Focus and Energy Formula Ogden, UT, Aug. 17, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights
17/08/2026
– Entitles holders to receive net proceeds from sale of remaining Legacy Biosimilar Assets – – Completes transformation of Coherus Oncology into a fully integrated, innovative immuno-oncology company – REDWOOD CITY, [...]
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that on August 14, 2026, the Compensation Committee of the Company’s Board of Directors (the “ [...]
Sagimet Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
17/08/2026
FOSTER CITY, Calif., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]
Precision Optics to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026
17/08/2026
LITTLETON, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]
Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor
17/08/2026
Nominating and Governance Chair Carol Burt to become Lead Director. Ron Taylor to retire after more than 21 years of service on Resmed’s Board of Directors. SAN DIEGO, Aug. 17, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD [...]

Pages